name:-0.064206123352051
name:-0.054553031921387
name:-0.0017859935760498
Amylin Pharmaceuticals, LLC Patent Filings

Amylin Pharmaceuticals, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Amylin Pharmaceuticals, LLC.The latest application filed is for "sustained release formulations using non-aqueous carriers".

Company Profile
2.56.74
  • Amylin Pharmaceuticals, LLC - Wilmington DE US
  • AMYLIN PHARMACEUTICALS, LLC - ASTRAZENECA PHARMACEUTICALS LP
  • AMYLIN PHARMACEUTICALS, LLC - San Diego CA US
  • Amylin Pharmaceuticals, LLC; - San Diego CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Sustained Release Formulations Using Non-aqueous Carriers
App 20200405815 - Houchin; Mary L. ;   et al.
2020-12-31
Methods For Treating Diabetes And Reducing Body Weight
App 20200222509 - Fineman; Mark ;   et al.
2020-07-16
Engineered Polypeptides Having Enhanced Duration Of Action With Reduced Immunogenicity
App 20180344813 - ERICKSON; Mary ;   et al.
2018-12-06
Methods For Treating Diabetes And Reducing Body Weight
App 20180333468 - FINEMAN; Mark ;   et al.
2018-11-22
Sustained Release Formulations Using Non-aqueous Carriers
App 20180271946 - HOUCHIN; Mary L. ;   et al.
2018-09-27
Methods for treating diabetes and reducing body weight
Grant 9,884,092 - Fineman , et al. February 6, 2
2018-02-06
Engineered Polypeptides Having Enhanced Duration Of Action
App 20170114114 - Erickson; Mary ;   et al.
2017-04-27
Engineered polypeptides having enhanced duration of action
Grant 9,593,154 - Erickson , et al. March 14, 2
2017-03-14
Glp-1 Receptor Agonist Compounds For Obstructive Sleep Apnea
App 20160361390 - Van Cauter; Eve
2016-12-15
Sustained Release Formulations Using Non-aqueous Carriers
App 20160346357 - HOUCHIN; Mary L. ;   et al.
2016-12-01
Hybrid polypeptides with selectable properties
Grant 9,453,063 - Levy , et al. September 27, 2
2016-09-27
Methods For Treating Diabetes And Reducing Body Weight
App 20160271225 - FINEMAN; Mark ;   et al.
2016-09-22
Engineered polypeptides having enhanced duration of action with reduced immunogenicity
Grant 9,382,304 - Erickson , et al. July 5, 2
2016-07-05
Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent
App 20160120950 - Jennings; Robert N. ;   et al.
2016-05-05
Formulation delivery device
Grant 9,248,240 - Casey , et al. February 2, 2
2016-02-02
C-terminal amidation of polypeptides
Grant 9,249,181 - Sun , et al. February 2, 2
2016-02-02
Polymer-based sustained release device
Grant 9,238,076 - Wright , et al. January 19, 2
2016-01-19
GLP-1 receptor agonist compounds having stabilized regions
Grant 9,217,022 - Alfaro-Lopez , et al. December 22, 2
2015-12-22
GLP-1 receptor agonists for islet cell transplantation
Grant 9,161,953 - Osei October 20, 2
2015-10-20
Glp-1 Receptor Agonist Compounds For Obstructive Sleep Apnea
App 20150258177 - Van Cauter; Eve
2015-09-17
GIP analog and hybrid polypeptides with selectable properties
Grant 9,133,260 - Levy , et al. September 15, 2
2015-09-15
Exendins To Lower Cholesterol And Triglycerides
App 20150238568 - Fineman; Mark ;   et al.
2015-08-27
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same
App 20150231204 - LEVY; Odile Esther ;   et al.
2015-08-20
Insulin-pramlintide Compositions And Methods For Making And Using Them
App 20150174209 - Chiquette; Elaine ;   et al.
2015-06-25
Transmucosal Delivery Of Peptides And Proteins
App 20150157725 - ONG; John ;   et al.
2015-06-11
Methods To Restore Glycemic Control
App 20150152158 - RABINOVITCH; Alex ;   et al.
2015-06-04
Methods For Treating Diabetes And Reducing Body Weight
App 20150150948 - FINEMAN; Mark ;   et al.
2015-06-04
Method of lowering cholesterol and triglycerides by administering exendins
Grant 9,034,819 - Fineman , et al. May 19, 2
2015-05-19
Transmucosal Delivery Of Engineered Polypeptides
App 20150133373 - Ren; Steven Shijun ;   et al.
2015-05-14
Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent
App 20150111824 - JENNINGS; Robert N. ;   et al.
2015-04-23
Site-specific Enzymatic Modification Of Exendins And Analogs Thereof
App 20150111246 - Samant; Manoj P. ;   et al.
2015-04-23
Formulations and Uses of Exendins and Exendin Agonist Analogs
App 20150080308 - KOLTERMAN; Orville G. ;   et al.
2015-03-19
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility
App 20150080307 - YOUNG; Andrew A. ;   et al.
2015-03-19
Sustained Release Formulations Using Non-aqueous Carriers
App 20150056285 - HOUCHIN; Mary L. ;   et al.
2015-02-26
Modified exendins and exendin agonists
Grant 8,951,962 - Prickett , et al. February 10, 2
2015-02-10
Use of exendin and analogs thereof to delay or prevent cardiac remodeling
Grant 8,946,149 - Anderson , et al. February 3, 2
2015-02-03
Microcrystalline Y receptor agonists
Grant 8,927,687 - Ren January 6, 2
2015-01-06
Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same
App 20140371148 - GHOSH; Soumitra S. ;   et al.
2014-12-18
Method for treating diabetes
Grant 8,906,851 - Fineman , et al. December 9, 2
2014-12-09
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
Grant 8,906,849 - Levy , et al. December 9, 2
2014-12-09
GIP and exendin hybrid polypeptides
Grant 8,895,498 - Levy , et al. November 25, 2
2014-11-25
Sustained release formulations using non-aqueous carriers
Grant 8,895,033 - Houchin , et al. November 25, 2
2014-11-25
Hybrid Polypeptides With Selectable Properties
App 20140249299 - Levy; Odile Esther ;   et al.
2014-09-04
Amylin-calcitonin Chimeric Peptides Conjugated To Duration Enhancing Moieties
App 20140249076 - Samant; Manoj P. ;   et al.
2014-09-04
Long Duration Dual Hormone Conjugates
App 20140221282 - Sun; Chengzao ;   et al.
2014-08-07
Drug delivery device
Grant 8,790,314 - Casey July 29, 2
2014-07-29
Methods To Restore Glycemic Control
App 20140206613 - RABINOVITCH; Alex ;   et al.
2014-07-24
Treatment Of Cardiac Arrhythmias
App 20140200183 - HATHAWAY; David R. ;   et al.
2014-07-17
Peptide-peptidase inhibitor conjugates and methods of using same
Grant 8,759,295 - Ghosh , et al. June 24, 2
2014-06-24
Methods of treatment using exendin peptides or GLP-1 peptides
Grant 8,759,291 - Young , et al. June 24, 2
2014-06-24
N-terminus Conformationally Constrained Glp-1 Receptor Agonist Compounds
App 20140162943 - ALFARO-LOPEZ; Josue ;   et al.
2014-06-12
Methods for affecting body composition using amylin agonists
Grant 8,748,375 - Mack , et al. June 10, 2
2014-06-10
Peptide Yy And Peptide Yy Agonists For Treatment Of Metabolic Disorders
App 20140135261 - PITTNER; Richard A. ;   et al.
2014-05-15
Engineered Polypeptides Having Enhanced Duration Of Action
App 20140107019 - ERICKSON; Mary ;   et al.
2014-04-17
Methods For Affecting Body Composition
App 20140066368 - Mack; Christine Marie ;   et al.
2014-03-06
Polypeptide Conjugate
App 20140066370 - Forood; Behrouz Bruce ;   et al.
2014-03-06
Glp-1 Receptor Agonist Compounds For Obstructive Sleep Apnea
App 20140056924 - VAN CAUTER; Eve
2014-02-27
Modified Exendins And Exendin Agonists
App 20140038891 - Prickett; Kathryn S. ;   et al.
2014-02-06
N-terminus conformationally constrained GLP-1 receptor agonist compounds
Grant 8,642,544 - Alfaro-Lopez , et al. February 4, 2
2014-02-04
Pen injection device and method of using same
Grant 8,636,689 - Halili, Jr. , et al. January 28, 2
2014-01-28
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility
App 20130331322 - Young; Andrew A. ;   et al.
2013-12-12
Pancreatic polypeptide family motifs and polypeptides comprising the same
Grant 8,603,969 - Levy , et al. December 10, 2
2013-12-10
GLP-1 receptor agonist bioassay
Grant 8,603,761 - Nicolaou , et al. December 10, 2
2013-12-10
Methods for treatment using amylin family peptides
Grant 8,598,120 - Soares , et al. December 3, 2
2013-12-03
Peptide-peptidase-inhibitor conjugates and methods of making and using same
Grant 8,598,314 - Ghosh , et al. December 3, 2
2013-12-03
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same
App 20130303442 - LEVY; Odile Esther ;   et al.
2013-11-14
Microcrystalline Y Receptor Agonists
App 20130296225 - Ren; Steven Shijun
2013-11-07
Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties
App 20130281374 - Levy; Odile Esther ;   et al.
2013-10-24
Engineered Polypeptides Having Enhanced Duration Of Action
App 20130274182 - Erickson; Mary ;   et al.
2013-10-17
Treatment of hibernating myocardium with an exendin peptide
Grant 8,551,947 - Coolidge , et al. October 8, 2
2013-10-08
Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating Disorders
App 20130225485 - Weyer; Christian ;   et al.
2013-08-29
Prevention And Treatment Of Cardiac Arrhythmias
App 20130209586 - HATHAWAY; David R. ;   et al.
2013-08-15
Highly Soluble Leptins
App 20130203661 - Erickson; Mary
2013-08-08
Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
Grant 8,501,693 - Kim , et al. August 6, 2
2013-08-06
Gip Analog And Hybrid Polypeptides With Selectable Properties
App 20130196913 - Levy; Odile Esther ;   et al.
2013-08-01
DPP-IV resistant GIP hybrid polypeptides with selectable properties
Grant 8,497,240 - Levy , et al. July 30, 2
2013-07-30
Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis
Grant 8,481,490 - Tatarkiewicz , et al. July 9, 2
2013-07-09
Methods for Treating Diabetes and Reducing Body Weight
App 20130172243 - Fineman; Mark ;   et al.
2013-07-04
Exendins To Lower Cholesterol And Triglycerides
App 20130172250 - FINEMAN; Mark ;   et al.
2013-07-04
Formulations of Exendins and Exendin Agonist Analogs
App 20130165379 - Kolterman; Orville G. ;   et al.
2013-06-27
Gip Analog And Hybrid Polypeptides With Selectable Properties
App 20130137631 - LEVY; Odile Esther ;   et al.
2013-05-30
Polymer-based Sustained Release Device
App 20130130977 - Wright; Steven G. ;   et al.
2013-05-23
Modified exendins and exendin agonists
Grant 8,445,647 - Prickett , et al. May 21, 2
2013-05-21
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
Grant 8,426,361 - Levy , et al. April 23, 2
2013-04-23
Glp-1 Receptor Agonist Bioassay
App 20130089878 - Nicolaou; Michalis ;   et al.
2013-04-11
GIP analog and hybrid polypeptides with selectable properties
Grant 8,404,637 - Levy , et al. March 26, 2
2013-03-26
Methods of treating obesity with two different anti-obesity agents
Grant 8,394,765 - Roth , et al. March 12, 2
2013-03-12
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
Grant 8,389,472 - Baron , et al. March 5, 2
2013-03-05
Treatment of cardiac arrhythmias
Grant 8,389,473 - Hathaway , et al. March 5, 2
2013-03-05
Amylin and amylin agonists for treating psychiatric diseases and disorders
Grant 8,389,477 - Laugero , et al. March 5, 2
2013-03-05
Neuromedin and FN-38 Peptides for Psychotic Diseases
App 20130035294 - Laugero; Kevin D. ;   et al.
2013-02-07
Methods To Restore Glycemic Control
App 20130023471 - Rabinovitch; Alex ;   et al.
2013-01-24
Exendin And Exendin Agonists For Eating Disorders
App 20130023470 - Young; Andrew A. ;   et al.
2013-01-24
Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders
App 20130023466 - PITTNER; Richard A. ;   et al.
2013-01-24
GLP-1 receptor agonist bioassays
Grant 8,329,419 - Nicolaou , et al. December 11, 2
2012-12-11
Methods for treating diabetes and reducing body weight
Grant 8,329,648 - Fineman , et al. December 11, 2
2012-12-11
Neuromedin and FN-38 peptides for treating psychiatric diseases
Grant 8,309,522 - Laugero , et al. November 13, 2
2012-11-13
Methods to restore glycemic control
Grant 8,299,024 - Rabinovitch , et al. October 30, 2
2012-10-30
Exendin and exendin agonists for eating disorders
Grant 8,288,338 - Young , et al. October 16, 2
2012-10-16
Method of modifying food preference comprising administering amylin or amylin agonist
Grant 8,278,267 - Weyer , et al. October 2, 2
2012-10-02
Methods of treating obesity using PYY[3-36]
Grant 8,273,713 - Pittner , et al. September 25, 2
2012-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed